Follistatin-like-1, a diffusible mesenchymal factor determines the fate of epithelium

Mesenchyme is generally believed to play critical roles in "secondary induction" during organogenesis. Because of the complexity of tissue interactions in secondary inductions, however, little is known about the precise mechanisms at the cellular and molecular levels. We have demonstrated...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 107; no. 10; pp. 4601 - 4606
Main Authors Umezu, Tomohiro, Yamanouchi, Hiromi, Iida, Yusuke, Miura, Masataka, Tomooka, Yasuhiro, Donahoe, Patricia K.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 09.03.2010
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mesenchyme is generally believed to play critical roles in "secondary induction" during organogenesis. Because of the complexity of tissue interactions in secondary inductions, however, little is known about the precise mechanisms at the cellular and molecular levels. We have demonstrated that, in mouse oviductal development, the mesenchyme determines the fate of undetermined epithelial cells to become secretory or cilial cells. We have established a model for studying secondary induction by establishing clonal epithelial and mesenchymal cell lines from perinatal p53 -/- mouse oviducts. The signal sequence trap method collected candidate molecules secreted from mesenchymal cell lines. Naive epithelial cells exposed to Follistatin-like-1 (Fstl1), one of the candidates, became irreversibly committed to expressing a cilial epithelial marker and differentiated into ciliated cells. We concluded that Fstl1 is one of the mesenchymal factors determining oviductal epithelial cell fate. This is a unique demonstration that the determination of epithelial cell fate is induced by a single diffusible factor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: T.U. and Y.T. designed research; T.U., H.Y., Y.I., and M.M. performed research; T.U. and H.Y. contributed new reagents/analytic tools; T.U. and H.Y. analyzed data; and T.U. and Y.T. wrote the paper.
Edited by Patricia K. Donahoe, Massachusetts General Hospital, Boston, MA, and approved January 27, 2010 (received for review September 1, 2009)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0909501107